Wellstar Health System, one of Georgia’s largest and most integrated healthcare systems, announced that the Wellstar Cancer Network was recently recognized nationally as a cancer treatment leader. Honored with an Outstanding Achievement Award from the American College of Surgeons Commission on Cancer and designated as a Care Continuum Center of Excellence by the GO2 Foundation for Lung Cancer, the Wellstar Cancer Network continues to pioneer innovative cancer treatments and technologies to improve outcomes and quality of life for patients.
“Wellstar Health System is dedicated to providing patients with the highest quality of compassionate and personalized care,” said Dr. Michael Andrews, Chief Cancer Officer of the Wellstar Cancer Network. “We are extremely proud of the Wellstar Cancer Network and our team of highly skilled physicians, nurses and oncology support services who excel at treating the spectrum of cancer illnesses with the most advanced, patient-centric technologies and treatments. We are focused on enhancing the health and well-being of everyone we serve, with a commitment to delivering world-class cancer care.”
Wellstar earned an Outstanding Achievement Award for the third consecutive cycle from the American College of Surgeons Commission on Cancer (CoC). The highest honor in the United States awarded to a cancer program, the Wellstar Cancer Network was recognized for achieving excellence in providing care to cancer patients. Award recipients must have received commendation ratings in all seven commendation standards and receive a compliance rating for each of the 27 remaining cancer program standards.
Wellstar Recognized as Cancer Treatment Leader
Published on October 12, 2020
Last updated 02:04 PM October 16, 2020
Wellstar Cancer Care Receives National Recognition with Outstanding Achievement Award, Designated as Care Continuum Center of Excellence for Lung Cancer
The purpose of the award is to raise the bar on quality cancer care, with the ultimate goal of increasing awareness about quality care choices among cancer patients and their loved ones. In addition, the award is intended to:
- Recognize those cancer programs that achieve excellence in providing quality care to cancer patients.
- Motivate other cancer programs to work toward improving their level of care.
- Facilitate dialogue between award recipients and health care professionals at other cancer facilities for the purpose of sharing best practices.
- Encourage honorees to serve as quality care resources to other cancer programs.
“More and more, we’re finding that patients and their families want to know how the health care institutions in their communities compare with one another,” said Lawrence N. Shulman, MD, MACP, chair of the CoC. “They want access to information in terms of who’s providing the best quality of care, and they want to know about overall patient outcomes. Through this recognition program, I’d like to think we’re playing a small but vital role in helping them make informed decisions on their cancer care.”
Wellstar was also recognized by the Care Continuum Centers of Excellence (CCCOE), a program of the GO2 Foundation for Lung Cancer which identifies community hospitals that meet rigorous qualifying criteria and demonstrate collaborative leadership across the lung cancer care continuum. GO2 Foundation formed the Care Continuum Centers of Excellence program to enable patient access to standard of care lung cancer screening, early detection, diagnosis, treatment and survivorship in their local community. Meeting the CCCOE criteria puts member hospitals on par with leading academic and research institutions and provides patients with access to the latest innovations not typically found in community hospitals. The CCCOE program promotes a standard of compassionate and timely care excellence with, as well as treatment options that improve survivorship.
“We are proud and honored to be working with Wellstar Health System as a GO2 Foundation Care Continuum Center of Excellence. Their commitment will help save lives and improve long-term survivorship by giving patients access to high-quality, multidisciplinary care closer to home. They are the example to follow,” says Laurie Fenton Ambrose, co-founder, president and CEO of GO2 Foundation.